A Randomized, Multicenter, Double Blind, Phase III Study of Adjuvant Nivolumab or Placebo in Subjects with Resected Esophageal, or Gastroesophageal Junction Cancer
| Title | A Randomized, Multicenter, Double Blind, Phase III Study of Adjuvant Nivolumab or Placebo in Subjects with Resected Esophageal, or Gastroesophageal Junction Cancer |
|---|---|
| Description | Primary Clinical Study Report for Foreign Health Authority |
| Organism | Homo sapiens |
| Data Type | Other Type of Clinical information |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA013148 |
| Release Date | 2022-12-31 |
| Submitter | Wentao Fang (vwtfang@hotmail.com) |
| Organization | Shanghai Chest Hospital |
| Submission Date | 2022-11-11 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX002319-01 | CA209-577 CSR Foreign HA | 103 | Other Type of Clinical information | 1.6 MB | zip | 0 | Controlled |